NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

january, 2015

08jan2:00 pmConsiderations for Establishing CHG Bathing Protocols

Event Details

Download Webinar Workbook

This 90-minute webinar will feature Rosie D. Lyles, MD, MHA, MSc.

Dr. Lyles is the Head of Clinical Affairs for the Clorox Professional Products Company where she serves as a research fellow and primary medical science liaison for the healthcare business, supporting all scientific research as well as clinical and product intervention design and development. Dr. Lyles previously served as a physician researcher and study director for multiple epidemiologic research initiatives in the Division of Infectious Diseases at the Cook County Health and Hospitals System, investigating healthcare-associated infections with a particular focus on the epidemiology and prevention of multidrug-resistant organisms (MDROs) and infections in ICU settings.

Dr. Lyles’ presentation will provide useful background information and key insights on the use of chlorhexidine gluconate (CHG) products for skin cleansing and review key practice considerations for CHG bathing protocols in both intensive care units (ICU) and pre-operative settings. The presentation will review applications for CHG bathing protocol used to reduce the risk of a broad range of infections, as well as key criteria for implementing a standardized protocol and innovative ways to improve patient compliance. There will also be an opportunity for participants to ask questions.

Sponsor

clorox-logo-150x84

OR Today would like to thank our sponsor, Clorox Healthcare! Clorox Healthcare markets some of the most trusted healthcare brands, with a portfolio that includes bleach, hydrogen peroxide, quaternary products and a range of skin antiseptic products, reinforcing the company’s commitment to help stop the spread of infections. For more information, visit: www.CloroxHealthcare.com.

X